Now Available for Public Comment: Notice of Proposed Rulemaking (NPRM) for FDAAA 801 and NIH Draft Reporting Policy for NIH-Funded Trials
277 studies found for:    "Expanded Access" [STUDY-TYPES]
Show Display Options
RSS Create an RSS feed from your search for:
"Expanded Access" [STUDY-TYPES]
Need help? See RSS Feeds
Choose a feed type:
Show studies that were first received in the last 14 daysShow studies that were first received in the last 14 days
Show studies added or modified in the last 14 daysShow studies that were added or modified in the last 14 days
Rank Status Study
1 Available Islet Transplant for Type 1 or Surgical Diabetes
Conditions: Type 1 Diabetes Mellitus;   Hypoglycemia;   Labile Diabetes;   End-stage Renal Disease
Intervention: Biological: Allogeneic islets of Langerhans
2 Approved for marketing Use of Avanta Metacarpophalangeal (MCP) Joint Implant Finger Prosthesis, Humanitarian Use Device
Condition: Arthroplasty of the MCP Joint
Intervention: Device: SR™MCP
3 Unknown  Special Access for the Use of Voclosporin for Kidney Transplantation
Conditions: Kidney Transplantation;   Immunosuppression
Intervention: Drug: Voclosporin
4 Available Expanded Access Program (EAP): Allow Patients in the US With Idiopathic Pulmonary Fibrosis Access to Pirfenidone
Condition: Idiopathic Pulmonary Fibrosis
Intervention: Drug: Pirfenidone
5 Available Expanded Access Protocol Using 131I-MIBG Therapy for Refractory Neuroblastoma, Pheochromocytoma, or Paraganglioma
Conditions: Neuroblastoma;   Pheochromocytoma;   Paraganglioma
Intervention: Radiation: I-131 MIBG
6 Unknown  Compassionate Use of Sodium Stibogluconate (Pentostam) for Cutaneous and Mucocutaneous New World Leishmaniasis
Conditions: Leishmaniasis, Cutaneous;   Leishmaniasis, Mucocutaneous
Intervention: Drug: sodium stibogluconate (Pentostam)
7 Available Osteopathic Approach Into Neonatology Ward: the NE-O Model
Condition: The Focus of the Study is to Provide a Guideline on Osteopathic Approach in Treating Hospitalized Newborns.
Intervention: Other: Osteopathic Manipulative Treatment
8 Approved for marketing Compassionate Use of Pennsaid Topical Lotion (Diclofenac) in Osteo or Rheumatoid Arthritis
Condition: Osteoarthritis of the Hand
Intervention: Drug: Diclofenac
9 Available Expanded Use of G-CSF Mobilized Donor CD34+ Selected Cells for Allogeneic Transplantation
Conditions: Chronic Myeloid Leukemia;   Myelodysplastic Syndrome;   Acute Myeloid Leukemia
Intervention: Biological: G-CSF mobilized CD34+ selected cells for transplantation
10 Approved for marketing Open Label Study to Assess Efficacy and Safety of the Fully Human Anti-TNF-Alpha Monoclonal Antibody Adalimumab
Condition: Rheumatoid Arthritis
Intervention: Biological: adalimumab
11 Unknown  131I-Labeled MIBG for Refractory Neuroblastoma: A Compassionate Use Protocol
Condition: Neuroblastoma
Intervention: Drug: Metaiodobenzylguanidine (MIBG)
12 Available Long-Term Compassionate Use Study for Continued Administration of SCB01A-01
Condition: Malignant Solid Tumour
Intervention: Drug: SCB01A
13 Available Expanded Access Study of Afatinib in Treatment-naive or Chemotherapy Pre-treated Patients With Non-small Cell Lung Cancer (NSCLC)
Condition: Carcinoma, Non-Small-Cell Lung
Intervention: Drug: Afatinib
14 No longer available Stiripentol in Dravet Syndrome
Condition: Dravet Syndrome
Intervention: Drug: stiripentol
15 Unknown  Dolutegravir Expanded Access Study
Condition: Infection, Human Immunodeficiency Virus
Intervention: Drug: dolutegravir
16 No longer available Cyclosporine Inhalation Solution (CIS) in Lung Transplant Recipients
Condition: Lung Transplant
Intervention: Drug: Cyclosporine Inhalation Solution
17 No longer available Use of the ELAD® in Patients With Liver Failure to Provide Expanded Access With Cost Recovery
Condition: Liver Failure
Intervention: Device: ELAD®
18 No longer available Treatment Protocol of Replagal for Patients With Fabry Disease
Condition: Fabry Disease
Intervention: Biological: agalsidase alfa
19 Available Keratoconus and Ectasia Treatment Plan
Conditions: Keratoconus;   Ectasia
Interventions: Other: Riboflavin Solution;   Device: UV-X Illumination System
20 No longer available Induction of Donor-Specific Tolerance in Recipients of Live Donor Stem Cell Infusion (Compassionate Use)
Condition: Renal Failure
Intervention: Biological: Biological/Vaccine: Enriched Hematopoetic Stem Cell Transplant

   Previous Page Studies Shown (1-20) Next Page (21-40) Show next page of results    Last Page
Indicates status has not been verified in more than two years